Correlation Between OHR Pharmaceutical and Invesco SP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OHR Pharmaceutical and Invesco SP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OHR Pharmaceutical and Invesco SP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OHR Pharmaceutical and Invesco SP 500, you can compare the effects of market volatilities on OHR Pharmaceutical and Invesco SP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OHR Pharmaceutical with a short position of Invesco SP. Check out your portfolio center. Please also check ongoing floating volatility patterns of OHR Pharmaceutical and Invesco SP.

Diversification Opportunities for OHR Pharmaceutical and Invesco SP

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between OHR and Invesco is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OHR Pharmaceutical and Invesco SP 500 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco SP 500 and OHR Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OHR Pharmaceutical are associated (or correlated) with Invesco SP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco SP 500 has no effect on the direction of OHR Pharmaceutical i.e., OHR Pharmaceutical and Invesco SP go up and down completely randomly.

Pair Corralation between OHR Pharmaceutical and Invesco SP

If you would invest  0.00  in OHR Pharmaceutical on January 20, 2024 and sell it today you would earn a total of  0.00  from holding OHR Pharmaceutical or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

OHR Pharmaceutical  vs.  Invesco SP 500

 Performance 
       Timeline  
OHR Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OHR Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, OHR Pharmaceutical is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Invesco SP 500 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco SP 500 are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable technical indicators, Invesco SP is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

OHR Pharmaceutical and Invesco SP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OHR Pharmaceutical and Invesco SP

The main advantage of trading using opposite OHR Pharmaceutical and Invesco SP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OHR Pharmaceutical position performs unexpectedly, Invesco SP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco SP will offset losses from the drop in Invesco SP's long position.
The idea behind OHR Pharmaceutical and Invesco SP 500 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Directory
Find actively traded commodities issued by global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules